Health Effects of a Nordic Diet Rich in Plant-based Foods and Fish
Study Details
Study Description
Brief Summary
The purpose of this study is to investigate the effects of a Nordic diet rich in plant-based foods and fish on indicators of cardiovascular disease risk at two different levels of salt intake.
The study is a 20-wk randomized controlled crossover trial. The subjects follow a salt-restricted diet during the study. The study begins with a 4-wk run-in phase for all subjects. After that the subjects are randomly allocated to one of two groups. Group 1 consumes a healthy Nordic low-salt diet enriched with plant-based foods and fish for 16 weeks. Group 2 consumes a low-salt diet for 16 weeks. During the 16 weeks, both groups receive salt and placebo capsules in a double-blind, crossover fashion (8+8 weeks).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Plant-based food and fish with salt restr. The subjects consume plant based foods (fruits, berries, vegetables, whole grain) and fish in addition to a salt-restricted diet. Intake of salt is normal to high for 8 weeks and low for 8 weeks (subjects receive salt and placebo capsules in a crossover design). |
Other: Effects of a Nordic diet rich in plant-based foods and fish
The intervention lasts for 20 weeks and it includes dietary counseling concerning salt restriction. Key foods are provided to the subjects.
|
Placebo Comparator: Diet with salt restriction The subjects follow a salt-restricted diet. Intake of salt is normal to high for 8 weeks and low for 8 weeks (subjects receive salt and placebo capsules in a crossover design). |
Other: Effects of a Nordic diet rich in plant-based foods and fish
The intervention lasts for 20 weeks and it includes dietary counseling concerning salt restriction. Key foods are provided to the subjects.
|
Outcome Measures
Primary Outcome Measures
- Change from baseline in systolic and diastolic blood pressure after treatments [12 and 20 weeks]
Secondary Outcome Measures
- Change from baseline in PFA-100 measurements after treatments [12 and 20 weeks]
- Change from baseline in biomarkers of cardiovascular disease risk after treatments [12 and 20 weeks]
- Change from baseline in nutritional biomarkers after treatments [12 and 20 weeks]
- Change from baseline in blood cell gene expression after treatments [12 and 20 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
- prehypertension or hypertension (systolic blood pressure 130-159 mmHg or diastolic blood pressure 85-99 mmHg)
Exclusion Criteria:
-
smoking
-
regular use of medications
-
intestinal disorders
-
symptomatic cardiovascular disease
-
obesity (BMI>35 kg/m2)
-
vegetarianism
-
high intake of alcohol
-
allergy to fish
-
pregnancy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | National Institute for Health and Welfare | Helsinki | Finland | FI-00271 |
Sponsors and Collaborators
- Finnish Institute for Health and Welfare
- Academy of Finland
- University of Oslo
Investigators
- Study Director: Iris Erlund, Dr., Finnish Institute for Health and Welfare
- Study Director: Antti Jula, Dr., Finnish Institute for Health and Welfare
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NPHIKTL_022011